Wesley Johnson - Jul 15, 2022 Form 4 Insider Report for ANGIODYNAMICS INC (ANGO)

Role
Director
Signature
/s/ Richard C. Rosenzweig, Attorney in Fact
Stock symbol
ANGO
Transactions as of
Jul 15, 2022
Transactions value $
$4
Form type
4
Date filed
7/18/2022, 04:16 PM
Previous filing
Apr 13, 2022
Next filing
Jul 22, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANGO Common Stock Options Exercise $96.1K +6.02K +7.56% $15.95 85.7K Jul 15, 2022 Direct
transaction ANGO Common Stock Tax liability -$96K -4.51K -5.26% $21.32 81.2K Jul 15, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ANGO Non- Qualified Stock Option (right to buy) Options Exercise $0 -6.02K -100% $0.00* 0 Jul 15, 2022 Common Stock 6.02K $15.95 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The exempt disposition of 4,505 shares of common stock of AngioDynamics, Inc. (the "Company") to the Company was made to satisfy the exercise price arising from a net (cashless) exercise of stock options that were set to expire on 7/22/2022.
F2 Options for one-third of the shares were each exercisable beginning 7/22/2016, 7/22/2017 and 7/22/2018, respectively.